Search Within

Malcolm A S Moore

  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (7)
Groups
  1. Cell Biology Program Faculty (20)
  2. Center for Hematologic Malignancies (20)
  3. GSK Faculty (20)
  4. Hematologic Malignancies Research (20)
  5. Molecular Pharmacology and Chemistry Program Faculty (20)
  6. Sloan Kettering Institute Faculty (20)

More Groups

People
  1. Michel Sadelain (12)
  2. Chad May (7)
  3. Karen Mackenzie (6)
  4. Sonia Franco (6)
  5. Gabriela Chiosis (5)
  6. Maria Caldas Lopes- Vazquez (5)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
  3. 2012 (2)
  4. 2005 (1)
  5. 2004 (1)
  6. 2002 (2)

More Years

Publications
  1. Blood (6)
  2. Cancer Research (3)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  4. Annals of Oncology (1)
  5. Experimental Cell Research (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Hematology (6)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Inc. (1)
  5. FEBS Press (1)
  6. Federation of American Societies for Experimental Biology (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma
    Journal Article

    Ambati, S. R.; Lopes, E. C.; Kosugi, K.; Mony, U.; Zehir, A.; Shah, S. K.; Taldone, T.; Moreira, A. L.; Meyers, P. A.; Chiosis, G.; more...
    Molecular Oncology (2014)

    Fulltext@MSK | Save
  • Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models
    Meeting Abstract

    Ambati, S. R.; Lopes, E. C.; Kosugi, K.; Mony, U.; Zehir, A.; Moreira, A. L.; Meyers, P. A.; Chiosis, G.; Moore, M. A. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Novel inhibitor of HSP90-PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models
    Meeting Abstract

    Ambati, S. R.; Caldas Lopes- Vazquez, M. E.; Mony, U.; Kosugi, K.; Moreira, A.; Meyers, P.; Chiosis, G.; Moore, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Novel purine scaffold Hsp90 inhibitor Pu-H71, exhibits significant activity in Ewing sarcoma pre-clinical models
    Meeting Abstract

    Ambati, S.; Lopes, E. C.; Kosugi, K.; Mony, U.; Peguero, E.; Moreira, A.; Meyers, P.; Chiosis, G.; Moore, M.
    Pediatric Blood and Cancer (2013)

    Fulltext@MSK | Save
  • L3MBTL1: A polycomb protein at the node of crosstalk between the BMP4 and hippo signaling pathways in erythropoiesis
    Meeting Abstract

    Perna, F.; Vu, L. P.; Themeli, M.; Hoya-Arias, R. ; Liu, F.; Wang, L.; Gurvich, N.; Hricik, T.; Papapetrou, E. P.; Moore, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Anti-apoptotic Bcl2 and Bcl-Xl proteins involved in stroma-induced drug tolerance to Hsp70 and Hsp90 inhibitors in leukemia and B-cell lymphoma
    Meeting Abstract

    Lopes, E. C.; Correa, F. M.; Shen, L. B.; Shieh, J.H.; Taldone, T.; Chiosis, G.; Moore, M. A. S.
    Blood (2012)

    Fulltext@MSK | Save
  • Genetic manipulation of bone marrow-derived endothelial progenitors to modulate sphingomyelinase-mediated endothelial cell apoptosis within tumors
    Meeting Abstract

    Varda Bloom, N.; Donepudi, M.; Bompais, H.; Chan, E.; Campodonico, L.; Sadelain, M.; Moore, M. A. S.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins
    Journal Article

    Moldenhauer, A.; Frank, R. C.; Pinilla-Ibarz, J.; Holland, G.; Boccuni, P.; Scheinberg, D. A.; Salama, A.; Seeger, K.; Moore, M. A. S.; Nimer, S. D.
    Journal of Leukocyte Biology (2004)

    Fulltext@MSK | Save
  • Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras
    Journal Article

    Mackenzie, K. L.; Franco, S.; Naiyer, A. J.; May, C.; Sadelain, M.; Rafii, S.; Moore, M. A. S.
    Oncogene (2002)

    Fulltext@MSK | Save
  • Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts
    Journal Article

    Boklan, J.; Nanjangud, G.; Mackenzie, K. L.; May, C.; Sadelain, M.; Moore, M. A. S.
    Cancer Research (2002)

    Fulltext@MSK | Save